F-star Therapeutics, Inc.
FSTX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Market Cap | $83,570 | $64,779 | $64,672 | $104,233 |
| - Cash | $78,549 | $18,526 | $4,901 | $14,724 |
| + Debt | $13,234 | $3,161 | $15,568 | $0 |
| Enterprise Value | $18,255 | $49,414 | $75,339 | $89,509 |
| Revenue | $21,167 | $11,256 | $28,321 | $0 |
| % Growth | 88.1% | -60.3% | – | – |
| Gross Profit | $21,167 | $11,256 | $28,321 | $0 |
| % Margin | 100% | 100% | 100% | – |
| EBITDA | -$29,421 | -$21,241 | -$13,349 | -$28,470 |
| % Margin | -139% | -188.7% | -47.1% | – |
| Net Income | -$31,283 | -$25,619 | -$23,013 | -$22,854 |
| % Margin | -147.8% | -227.6% | -81.3% | – |
| EPS Diluted | -1.88 | -2.82 | -2.54 | -1.6 |
| % Growth | 33.3% | -11% | -58.7% | – |
| Operating Cash Flow | -$27,267 | -$16,226 | -$22,111 | -$25,244 |
| Capital Expenditures | -$658 | -$730 | -$127 | -$1,972 |
| Free Cash Flow | -$27,925 | -$16,956 | -$22,238 | -$27,216 |